ADIM
MGNX icon

Alpha DNA Investment Management’s MacroGenics MGNX Stock Holding History

Alpha DNA Investment Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-156,937
Closed -$1.13M – 202
2023
Q1 		$1.13M Buy
+156,937
New +$945K 0.33% 73

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Alpha DNA Investment Management's MGNX Position: Q2 2023 in Review

Alpha DNA Investment Management sold out of MacroGenics (MGNX) in Q2 2023, closing a stake of 156,937 shares — an estimated $1.13M sold.

Alpha DNA Investment Management first reported a position in MGNX in Q1 2023 and held it in 1 quarter. The position peaked at $1.13M in Q1 2023. 131 funds tracked by Wall St. Rank hold MGNX as of Q2 2023.

  • Alpha DNA Investment Management reported no remaining MacroGenics position as of Q2 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 156,937 MacroGenics shares in Q2 2023, an estimated $1.13M.
  • Alpha DNA Investment Management first reported a position in MacroGenics in Q1 2023 and held it in 1 quarter.
  • Alpha DNA Investment Management's MacroGenics position peaked at $1.13M in Q1 2023.
  • 131 funds tracked by Wall St. Rank held MacroGenics as of Q2 2023.

Based on Alpha DNA Investment Management's 13F filing for Q2 2023, filed 31 Jul 2023.